Pioneering heart disease treatment

August 15, 2012
Pioneering heart disease treatment

(Medical Xpress) -- Researchers at King's College London have developed the first artificial functioning blood vessel outside of the body, made from reprogrammed stem cells from human skin. The team also saw the cells develop into a blood vessel inside the body for the first time. 

The new technique could have real potential to treat patients with – the biggest killer in the UK – by either injecting the reprogrammed into the leg or heart to restore blood flow or grafting an artificially developed vessel into the body to replace blocked or damaged vessels. The treatment could also benefit diabetic patients with poor circulation, preventing leg amputation. 

Stem cell therapy to treat heart disease is already being carried out in the clinic using bone marrow cells, however, the long-term effectiveness at the moment is minimal and some types of have the potential to become a tumour after they are introduced into the body. Published in the journal Proceedings of the National Academy of Sciences, this new study demonstrates that a new type of partial stem cell developed from fibroblasts () can be reprogrammed into before going into the body, which have no risk turning into tumours.

The King’s team introduced four genes to human fibroblasts in the laboratory to reprogramme them into partial stem cells so they could become vascular cells. When these newly created cells were injected into an ischemic leg (a leg with restricted blood flow) in an animal model, the function of the leg was improved. 

The process of developing vascular cells from skin cells took two weeks, which makes a personalised approach of turning a patient’s own skin cells into vascular cells feasible for treatment of vessel-blocking related diseases. The researchers say the next step is to test this approach in cells from patients with vascular disease.

Professor Qingbo Xu, British Heart Foundation and John Parker Chair at King’s College London, said: "This is very exciting research – we are thrilled to have developed the first artificial functioning blood vessel outside of the body made from stem cells derived from human fibroblasts."

"Heart disease is the biggest killer in this country, so if we can develop this approach as personalised treatments for patients with the condition, it will be a significant step forward. This is an early study and more research needs to be done into how this approach works in patients, but the aim is to be able to inject reprogrammed cells into areas of restricted , or even graft an entirely new blood vessel into a patient to treat serious cardiovascular diseases."

Dr Hélène Wilson, Research Advisor at the British Heart Foundation, which co-funded the study, said: ‘This breakthrough is an exciting step forward in the field of regenerative medicine, but further studies and safety checks will need to be carried out before we know if it will help lead to new treatments for patients.

"This team showed they can derive so-called ‘partial pluripotent’ cells from cells in just four days, and convert them directly into a type of cell that lines our . Traditional methods take longer and come with an increased chance of tumours forming from the new cells."

"The discovery could help lead towards future therapies to repair hearts after they are damaged by a heart attack. As well as playing a part in a possible future regenerative treatment, these cells might also be used in drug screening to find new treatments to tackle inherited diseases."

Explore further: Cambridge team first to grow smooth muscle cells from patient skin cells

More information: www.pnas.org/content/early/201 … 526109.full.pdf+html

Related Stories

Cambridge team first to grow smooth muscle cells from patient skin cells

January 26, 2012
A Cambridge University research team has for the first time discovered a method of generating different types of vascular smooth muscle cells (SMCs) - the cells which make up the walls of blood vessels - using cells from ...

Stem cell innovation jump-starts circulation

March 8, 2012
A stem cell breakthrough at the Technion-Israel Institute of Technology could ultimately benefit human patients struggling to recover from cardiovascular disease, or serious circulatory damage from conditions such as diabetes.   Programming ...

Stem cells from cord blood could help repair damaged heart muscle

October 13, 2011
(Medical Xpress) -- New research has found that stem cells derived from human cord blood could be an effective alternative in repairing heart attacks.

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.